CHEETAH Trial Testing Measures To Reduce Surgical Site Infections
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2020/02/023606
- Lead Sponsor
- niversity Of Birmingham
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 4000
Hospital Inclusion Criteria:
1. Hospitals where glove and instrument change is not currently routine practice
Patient Inclusion Criteria:
Patients undergoing abdominal surgery who satisfy the following criteria are eligible:
1a. Emergency (surgery on an unplanned admission) or elective (surgery on a planned admission)
1b. Intraoperative finding of clean-contaminated, contaminated or dirty surgery.
1c. With at least one abdominal incision that is equal to or greater than 5 cms
2. Patients aged 5 years and above
Country Inclusion Criteria:
1. Low and Middle Income Country as defined by DAC ODA list
2. At least 4 eligible hospitals per country
1. Patients undergoing caeserian section
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Surgical Site Infections within 30 days of surgeryTimepoint: 30 days after surgery
- Secondary Outcome Measures
Name Time Method 1. Unexpected re-admission into hospital for a wound-related problem within 30- <br/ ><br>days post surgery. <br/ ><br>2. Unexpected re-operation for a wound-related problem within 30-days post <br/ ><br>surgery. <br/ ><br>3. Length of hospital stay. <br/ ><br>4. Return to normal activities (e.g. work, school, or family duties) within 30-days <br/ ><br>post surgery. <br/ ><br>5. Death within 30 days of surgery.Timepoint: Clinical outcomes thirty days post surgery